Using affinity-purified calmodulin-binding proteins from human epidermis we have developed a monoclonal IgM antibody, ROC 129
Introduction
Calcium has a profound effect on the physiology of keratinocytes in vitro. When keratinocytes are grown in low calcium conditions (0.01-0.09 mM) the cells proliferate rapidly, do not stratify, and fail to fully differentiate (1) (2) (3) . When calcium is restored to levels greater than 0.1 mM the proliferative rate slows, the cells stratify and begin to express a number of markers of terminal differentiation (1) (2) (3) . The triggering ofterminal differentiation is a complex process that involves activation of phosphotidyl inositol turnover, protein kinase C, and other calcium-dependent enzymes such as transglutaminase (4) (5) (6) (7) . The development ofcross-linked cell envelopes and formation of the stratum corneum are the end results ofterminal differentiation in vivo.
Many of the effects of calcium are modulated by the calcium-binding protein calmodulin. Calmodulin binds four calcium ions and, when bound, a configurational change exposes the central helical region of the protein which may then interact with a number of calmodulin-binding proteins (8) (9) (10) . A role for calmodulin has been indicated in hemidesmosome formation of corneal epithelium (1 1), however its role in desmosome formation is unclear. In an attempt to identify the molecular events by which calcium modulates desmosome assembly and terminal differentiation we are characterizing epidermal calmodulin-binding proteins. In this paper we report the characterization of a high molecular weight human calmodulinbinding protein that immunolocalizes to the desmosome.
Methods
Extraction andpartialpurification ofcalmodulin-bindingproteins. Human neonatal foreskin was obtained from circumcisions. The epidermis was separated from the dermis by heat treatment at 56°C for 45 s and was homogenized in a 50 mM Tris buffer, 3 mM MgSO4, 1 mM dithiothreitol, 0.1-mM CaCl2. Epidermal calmodulin-binding proteins were purified by affinity chromatography using a calmodulin affinity column (Bio-Rad, Richmond, CA) equilibrated with Tris buffer with I mM calcium as described by Wallace (12) . The epidermal extract was applied to the column and the calmodulin-binding proteins were eluted with the same buffer containing 1 mM EGTA instead ofCaCl2.
2-ml fractions were collected. The OD280 was measured and the ability to bind biotinylated calmodulin was tested in individual fractions by dot blot analysis.
Detection ofcalmodulin-binding proteins. Biotinylated calmodulin (bio-CaM)' was used to detect calmodulin-binding proteins immobilized on a nitrocellulose membrane after separation by SDS-PAGE or directly by dot blotting. Bio-CaM was prepared according to the methods of Billingsley (13) . Briefly, purified human erythrocyte calmodulin (Calbiochem Corp., La Jolla, CA) was biotinylated using biotin succinimide ester (Calbiochem) dissolved in NN-dimethylformamide in the presence of 1 mM calcium and incubated for 2 h at 4°C. The resulting biotinylated calmodulin was dialyzed against 50 mM Tris-HCI, pH 7.4, 150 mM NaCl, 1 mM CaCI2, and aliquots stored at -20°C. Proteins bound to nitrocellulose strips were blocked in 5% nonfat dried milk, then incubated in 10 ug of bio-CaM for 30 min. An avidin-alkaline phosphatase detection system (Vector Laboratories, Burlingame, CA) was used to detect proteins that had bound the bio-CaM. Control blots contained 5 mM EGTA in the calmodulin buffers.
Generation of monoclonal antibodies against calmodulin-binding proteins. 10 jg of the calmodulin-binding proteins were emulsified in complete Freund's adjuvant and used to immunize female BALB/c mice. Booster injections were given every 2 wk with the antigen in incomplete Freund's adjuvant. The mice were sacrificed 2 d after the final injection. The mouse splenocytes were fused with an NS-1 mouse myeloma cell line using PEG 1500 essentially according to the method of Kohler and Milstein (14) . Hybridomas were selected by addition of hypoxanthine, aminopterine, and thymidine to the medium. Hybridoma supernatants were screened for antibody production by a sandwich ELISA using the affinity-purified calmodulin-binding proteins immobilized on microtiter wells. The hybridomas, which reacted specifically with the calmodulin-binding proteins, were cloned by limiting dilution. Antibody isotyping was performed using a subisotyping kit (Hyclone Laboratories, Logan, UT). Ascites was produced by injection of 3 x 106 hybridoma cells into the peritoneal cavity ofpristane-primed BALB/c mice.
SDS polyacrylamide gel electrophoresis, isoelectric focusing, and immunoblotting. Keratome harvested human epidermis was extracted in 0.06 M Tris, 2% SDS, 5% # mercaptoethanol, 1 mM DTT, 1 mM EGTA, pH 6.8, plus 0.1 mM PMSF. The extracted proteins were separated by 7.5% SDS PAGE and electrophoretically transferred to nitrocellulose for immunoblot analysis (15, 16) . Similarly, two-dimensional analysis of samples was performed according to O'Farrell (17), using isoelectric focusing for the first dimension followed by SDS-PAGE and electrotransfer. The nitrocellulose sheets were blocked in 4% BSA and then reacted with ROC 129.1 ascites 1:1000 in BSA, followed by an '25I-labeled anti-mouse IgM, ,u chain specific (Zymed Labs Inc., San Francisco, CA). Radioactive protein bands were detected by autoradiography.
Additional The species specificity of the ROC 129.1 monoclonal antibody was tested by indirect IF using epithelial tissues from a variety of mammalian species. They included bovine tongue epithelium, neonatal mouse skin, and monkey skin.
Human mucosal and other epithelial tissues were also tested for reactivity with the ROC 129.1 monoclonal antibody by immunoperoxidase procedures. Briefly, 5-Mum sections offormalin-fixed, paraffin-embedded tissue were incubated for 30 min with a 1:100 dilution ofROC 129.1 followed by a biotinylated secondary antibody and an avidinbiotin-peroxidase complex. The enzyme reaction product was developed by a final incubation of the sections in amino-ethyl-carbazole (AEC) with 0.03% hydrogen peroxide. Sections treated with normal mouse serum were included as negative controls.
Biopsies from dermatologic disorders. Skin biopsy specimens of patients with pemphigus vulgaris (n = 2), pemphigus foliaceus (n = 4), and bullous pemphigoid (n = 1) were fixed in formalin and embedded in paraffin. Sections were cut from these blocks and tested with ROC 129.1 monoclonal antibody by the immunoperoxidase method as previously described.
Immunolocalization ofepitopes recognized by the monoclonal antibody by light microscopy. Skin organ cultures were used to determine if the epitope with which the monoclonal antibody reacted was intra-or extracellular. 2-mm pieces of human foreskin were incubated with ROC 129.1 monoclonal antibodies diluted 1:100 in keratinocyte growth medium (KGM; Clonetics Corp., La Jolla, CA) containing 0.1% saponin. Control viable foreskins received the ascites in KGM without saponin. After a 24-h incubation at 37°C in a 5% CO2 incubator the tissue was frozen and cryosectioned. Sections oftest and control skin were stained with FITC-conjugated goat anti-mouse IgM and examined with a Nikon fluorescent microscope.
Immunolocalization of epitopes by immunoelectronmicroscopy. Tissue sections of normal adult breast skin were fixed in 4% paraformaldehyde in phosphate buffer for 4 h at room temperature. The tissue was then embedded at low temperature and polymerized at -20°C with ultraviolet light using Lowicryl K4M (Polysciences, Inc., Warrington, PA). Thin sections on nickel grids were immunostained with ROC Fig. 1 (Fig. 3) . As seen in this figure, no staining was seen in the area of the basement membrane zone (BMZ). The (Fig. 4 C) . Nonblistered epidermis surrounding the subcorneal vesicles maintained the same staining pattern as normal epidermis. The two cases of pemphigus vulgaris and one bullous pemphigoid all showed staining patterns similar to normal epidermis even in involved areas (Fig. 4, A and B) .
TheROC 129.1 monoclonal antibody identifies an intracellular desmosome-associated epitope. In organ culture, epidermis, which had been permeabilized with 0.1% saponin and incubated with ROC 129.1, showed the same staining pattern described on cryosections of human epidermis (Fig. 5 A) . In contrast, nonpermeabilized epidermis showed no staining with ROC 129.1 (Fig. 5 B) .
Immunogold techniques showed immunoreactants located on the desmosomal plaque near the insertion of the intermediate filaments (Fig. 6) into epidermal desmosomes. Intermediate filaments not associated with the desmosomes did not bind the ROC 129.1 monoclonal antibody. The epitope recognized by the ROC 129.1 monoclonal antibody is linked to the cell-envelope fraction. The cell envelope fraction showed strong reactivity with ROC 129.1 antibody. In -7 Vs>.
., I Figure 6 . Immunoelectronmicroscopy with ROC 129.1 and gold labeled anti-mouse IgM on human epidermis. Normal adult skin was fixed in 4% paraformaldehyde, low temperature embedded, and thin sectioned. The sections were stained with ROC 129.1 (1:1,000) followed by gold labeled anti-mouse IgM. Gold particles localized ROC 129.1 reactivity to the plaque of epidermal desmosomes. Magnification, 64,000. addition, the pellet could adsorb out the ability ofthe monoclonal antibody to label the epidermis by indirect IF (Fig. 7 A and  B) . The pellet used to immunoadsorb the ROC 129.1 reacted strongly by direct IF with FITC-conjugated anti-mouse IgM, indicating the pellet had adsorbed rather than destroyed the antibody. The pellet was also able to abolish the reactivity of ROC 129.1 with the 250-kD polypeptide by Western blotting (Fig. 7 D) . A similar pellet was unable to adsorb bullous pemphigoid autoantibodies from a serum used as a control.
Discussion
Epidermal desmosome assembly is regulated by extracellular : calcium in vitro. Under low calcium conditions (0.01-0.09 mM) desmosomes fail to form, while switching the keratinocytes to high calcium (> 0.1 mM) will trigger desmosome assembly. During this calcium-induced assembly ofdesmosomes there is a redistribution of desmosome components. The desmoplakins and keratin filaments that have a perinuclear distribution under low calcium conditions move to the lateral margins ofthe cell surface in high calcium (19) (20) (21) . The desmocollins are distributed over the entire cell surface in low calcium and move to the lateral cell margins with the calcium switch (20) . Desmosome assembly is not affected by actinomycin D or cyclohexamide, indicating new synthesis of desmosome components is not needed (2) . Initially the desmosomes are asymmetric; over a period of 2-5 h they become fully formed and symmetric (2) . Calcium induction of desmosome assembly may occur through the direct interaction ofcalcium with desmosome components, or indirectly through calcium's effects on other regulatory proteins. Desmoglein I (160 kD) and desmocollins I and II (1 15, 100 kD), have been shown to bind calcium using a45Ca++ overlay technique (22, 23) . It is thought that calcium may interact directly with the extracellular portion of these transmembrane glycoproteins during desmosome assembly.
The role of the calcium regulatory protein, calmodulin, in desmosome formation is not clear. Low doses of the calmodulin inhibitor, W-7, which inhibits calmodulin kinase, do not prevent desmosome assembly in keratinocytes in vitro. However, higher doses of this calmodulin inhibitor, which will cause a more general inhibition of calmodulin-dependent proteins, will partially inhibit desmosome formation (24) . In contrast, calmodulin has been shown to be important in the formation of hemidesmosomes of corneal epithelium in vitro (1 1). The presence of a calmodulin-binding protein in bovine (25) and, as shown in this study, human desmosomes suggests further studies are needed to elucidate the role of calmodulin in desmosome physiology.
In this study we have demonstrated the presence of a human desmosomal protein that binds calmodulin in a calciumdependent manner. A calmodulin-binding protein termed desmocalmin has been previously described in bovine muzzle desmosomes (25) . It is possible that our protein may be the human homologue of desmocalmin, as it shares certain similarities in molecular weight and pI (250 and 5.3 compared with 240 and 5.5 kD reported for bovine desmocalmin). The (25) . As the 129.1 antigen colocalized with the insertion site of the keratin filaments into the desmosome, it is possible the two may exhibit similar biologic properties. The 250-kD polypeptide recognized by ROC 129.1 has been named keratocalmin, because of its restriction to epidermal keratinocytes and its calmodulin binding properties, until its relationship to desmocalmin can be determined.
Keratocalmin has an M, similar to that of desmoplakin I (240 kD), however desmoplakin I has a neutral pI as compared with 5.3 for keratocalmin (26) . In addition, desmoplakin has a much wider tissue distribution than is apparent for keratocalmin (27) . Recently the sequence of desmoplakin I/I1 has been reported (28) . As sequences are determined for the various desmosomal components, the exact relationship between keratocalmin and the other desmosomal components will become apparent.
Two pools of keratocalmin have been identified in human epidermis: the soluble pool, which was extracted initially in Tris buffer during preparation of the partially purified calmodulin-binding proteins, and the insoluble cell envelope-associated pool. The cell envelope fraction has previously been shown to contain desmosomal remnants by electron microscopy (18) . Based on preliminary extraction experiments ofkeratocalmin from human epidermis the insoluble pool may represent the major fraction of this protein. When desmosome assembly is induced by calcium in vitro, a further stabilization occurs which prevents disassembly by calcium chelating agents (23) . As both keratocalmin and desmoglein I are contained in an insoluble envelope-associated pool, this stabilization may involve cross-linking of some desmosomal components to the cell envelope (18) .
Though a pool of keratocalmin has been shown to be associated with the cell envelope fraction no staining ofthe stratum corneum was seen by immunofluorescent or immunohistochemical techniques. The failure of stratum corneum staining in likely due to lack of access of the antibody to the antigen within the highly cross-linked cell envelope. The envelope fraction is prepared by extensive extraction of the epidermis in NP-40, KC1, and then followed by trypsinization; this fraction was demonstrated to clearly absorb out the antibody reactivity from the ascites. These extraction conditions may expose antigenic sites not normally exposed by sectioning skin.
Desmosome components are the target of autoantibody formation in the blistering disorder pemphigus foliaceus (PF). In PF the patients develop antibodies against the transmembrane desmosomal glycoprotein, desmoglein I (29-31). The pathogenicity of the autoantibodies has been demonstrated by the ability ofthe human antibodies to induce blistering by passive transfer in neonatal mice (32) . The loss of reactivity of 129.1 staining within the blistering lesion of PF may indicate that keratocalmin is located near desmoglein I. The loss of staining is not likely to be due to autoantibody blocking because the staining of ROC 129.1 is preserved in perilesional skin, an area in which PF antibodies are bound (33) . Destruction ofdesmosomal components by the ensuing inflammatory events after PF antibodies are bound may explain the augmentation ofblister formation by complement and proteases found in some experimental systems (34) (35) (36) (37) (38) and the loss of ROC 129.1 reactivity in the base of the lesions.
These studies do not directly address the function ofkeratocalmin. However, its localization to the desmosome and destruction in PF warrant further investigation into its possible role in cell adhesion. In addition, keratocalmin arises between 8-12 wk of gestational age, the stage when fetal skin begins to stratify. This is similar to the appearance of other cell surface proteins which have importance in cell-cell attachment such as the pemphigus vulgaris antigen (39) . Because calmodulin and its binding proteins act to modulate cell function in a calciumdependent manner, we plan to further study the effects of this protein on calcium-dependent desmosome assembly.
